Skip to main content

Articles

Recent Articles

A20: Modeling B cell lymphoma in mice
Articles  —  1 October Oct 2017
Oncology

A20: Modeling B cell lymphoma in mice

Read More about A20: Modeling B cell lymphoma in mice
Strategic Partnership. Long-Term Success. Biometrics: A Complete Suite of Services for Early Clinical Data Management
Articles  —  25 August Aug 2017
Oncology

Strategic Partnership. Long-Term Success. Biometrics: A Complete Suite of Services for Early Clinical Data Management

Read More about Strategic Partnership. Long-Term Success. Biometrics: A Complete Suite of Services for Early Clinical Data Management
The Biosimilars Landscape: Strategies for Clinical and Commercial Success
Articles  —  15 August Aug 2017
Oncology

The Biosimilars Landscape: Strategies for Clinical and Commercial Success

Read More about The Biosimilars Landscape: Strategies for Clinical and Commercial Success
Clinical Endpoints and Adaptive Clinical Trials in Precirrhotic Nonalcoholic Steatohepatitis: Facilitating Development Approaches for an Emerging Epidemic
Articles  —  7 August Aug 2017
Oncology

Clinical Endpoints and Adaptive Clinical Trials in Precirrhotic Nonalcoholic Steatohepatitis: Facilitating Development Approaches for an Emerging Epidemic

Read More about Clinical Endpoints and Adaptive Clinical Trials in Precirrhotic Nonalcoholic Steatohepatitis: Facilitating Development Approaches for an Emerging Epidemic
Finding Your Target: Biomarker-Guided Adaptive Trial Design in Immuno-oncology
Articles  —  19 July Jul 2017
Oncology

Finding Your Target: Biomarker-Guided Adaptive Trial Design in Immuno-oncology

Read More about Finding Your Target: Biomarker-Guided Adaptive Trial Design in Immuno-oncology
How to Maximize Patient Recruitment in Oncology Trials
Articles  —  6 June Jun 2017
Oncology

How to Maximize Patient Recruitment in Oncology Trials

Read More about How to Maximize Patient Recruitment in Oncology Trials
Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic
Articles  —  12 May May 2017
Oncology

Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic

Read More about Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic
Implementing a Proactive Approach to Risk Management
Articles  —  25 April Apr 2017
Oncology

Implementing a Proactive Approach to Risk Management

Read More about Implementing a Proactive Approach to Risk Management
Comprehensive 10-color flow cytometry analysis of the neuroblastoma intratumoral immune response using the murine syngeneic Neuro-2a tumor model
Articles  —  5 April Apr 2017
Oncology

Comprehensive 10-color flow cytometry analysis of the neuroblastoma intratumoral immune response using the murine syngeneic Neuro-2a tumor model

Read More about Comprehensive 10-color flow cytometry analysis of the neuroblastoma intratumoral immune response using the murine syngeneic Neuro-2a tumor model
NASH: How to Conquer This Global Health Crisis
Articles  —  30 January Jan 2017
Oncology

NASH: How to Conquer This Global Health Crisis

Read More about NASH: How to Conquer This Global Health Crisis
A Skeletal Muscle Atrophy Study: Complexity, Specialty Procedures & Collaboration
Articles  —  3 January Jan 2017
Oncology

A Skeletal Muscle Atrophy Study: Complexity, Specialty Procedures & Collaboration

Read More about A Skeletal Muscle Atrophy Study: Complexity, Specialty Procedures & Collaboration
Structure of Proof of Concept Studies That Precede a Nonalcoholic Steatohepatitis Development Program
Articles  —  5 December Dec 2016
Oncology

Structure of Proof of Concept Studies That Precede a Nonalcoholic Steatohepatitis Development Program

Read More about Structure of Proof of Concept Studies That Precede a Nonalcoholic Steatohepatitis Development Program